Canopy Growth Corp (TSX:WEED)(NYSE:CGC) is going to be releasing its quarterly earnings later this month. And with its share price struggling since May, investors might be tempted to buy the stock before it announces its year-end results. Let’s take a closer look at the company to see whether it’s a good idea to buy now.
In its last earnings release back in February, Canopy Growth recorded significant sales growth numbers yet again. However, with a lot of cash burn and soaring expenses, there were plenty of red flags that kept the stock from gaining any momentum. The danger is that in Q4 it could be much of the same, as Canopy Growth has been very busy wheeling and dealing, which is sure to add some significant costs along the way, potentially sending the company even deeper into the red.
While Canopy Growth is playing the long game and looking to strengthen its position over the years, in the short term, it’s going to lead to a lot of pain. However, investors are aware of these challenges and likely aren’t expecting the company to produce an (operating) profit anytime soon. Otherwise, Canopy Growth wouldn’t be at a market cap of around $20 billion today.
Is excitement surrounding Canadian pot stocks fading?
The big risk for Canopy Growth isn’t related to its financials or whether it will meet expectations; rather, it’s that investors have so many more options to choose from, as the U.S. cannabis industry has been growing and capturing a lot of attention lately. There’s no denying that the opportunity south of the border is a lot more lucrative given how strong sales have been in California and in other states.
While Canopy Growth certainly looks to capitalize that through its plans for hemp and the acquisition of Acreage Holdings, it’s still a long-term play that could take years to be realized. Meanwhile, companies in the U.S. are already expanding their reach throughout the country.
In order for investors to get excited about Canopy Growth, the company will have to announce some progress or expectations for its plans for the U.S. because strong results in Canada may not be enough to lift the stock from where it is today. Industry developments or company announcements have typically given Canopy Growth a big boost in the past. Investors have looked for signs of the growth that might be coming down the pipe rather than what has already been achieved thus far.
Bottom line
Barring a significant announcement made at the Q4 release, I would be surprised if the company sees a big boost in its share price even after a strong earnings result. However, given we’ve seen many misses in the industry since legalization, I wouldn’t hold out hope that Canopy Growth will produce a positive surprise this time around.
It may not be until edibles are legalized until we see some excitement returning to Canadian pot stocks. For now, however, the focus appears to have shifted away, and while that might make Canopy Growth an appealing buy today given its softer price, I wouldn’t expect the stock to get a big boost after the company releases its earnings this month.
You might be missing out on one of the biggest opportunities in Canadian investing history…
Marijuana was legalized across Canada on October 17th, and a little-known Canadian company just unlocked what some experts think could be the key to profiting off the coming marijuana boom.
Besides making key partnerships with Facebook and Amazon, they’ve just made a game-changing deal with the Ontario government.
One grassroots Canadian company has already begun introducing this technology to the market – which is why legendary Canadian investor Iain Butler thinks they have a leg up on Amazon in this once-in-a-generation tech race.
This is the company we think you should strongly consider having in your portfolio if you want to position yourself wisely for the coming marijuana boom.
More reading
- Why Aurora Cannabis (TSX:ACB) Doesn’t Fear a Supply Glut
- Marijuana Stocks Are Tumbling: Here’s What You Should Buy
- You Won’t Believe How Much $10,000 Invested in Canopy Growth (TSX:WEED) in 2014 Is Worth Today
- The Best Stocks to Get Exposure to the Defensive Healthcare Sector
- Where Will Canopy (TSX:WEED) Be in 5 Years?
Fool contributor David Jagielski has no position in any of the stocks mentioned.
Source: The Fool
Should You Buy Canopy Growth (TSX:WEED) Ahead of Earnings?
The Fool
In all we do, we take a different approach.
We believe – and have proven over decades – that the individual investor can beat the market.
We believe that anyone can do it, even if they don’t have a lot of time or money to devote to investing.
We believe in a long-term outlook, helping people build wealth over time.
We believe that the person best positioned to take care of your financial future is you.
And we work tirelessly on behalf of our hundreds of thousands of members who are enjoying the opportunities that come with having enough money to do the things that matter to them.
While we are headquartered in Alexandria, Va., The Motley Fool advocates for the individual investor around the globe with offices in the UK, Australia, Canada, Singapore, and Germany.
